We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Gilead’s antiviral drug remdesivir showed clinical improvement in two-thirds of COVID-19 patients in a study at Los Angeles’ Cedars-Sinai Hospital. Read More
Eli Lilly’s arthritis treatment Olumiant (baricitinib) is being investigated as a potential COVID-19 treatment in one arm of a National Institutes for Allergy and Infectious Diseases adaptive trial. Read More
Researchers planning trials on the use of convalescent blood plasma to treat COVID-19 must submit an investigational new drug (IND) application, according to a new FDA final guidance that will remain in effect only for the duration of the public health emergency. Read More
Rep. Diana DeGette (D-Colo.) has called on the FDA to ensure that supplies of hydroxychloroquine and chloroquine are saved for approved indications, citing reports of hoarding. Read More